REGENERON PHARMACEUTICALS, INC. (REGN)
Nasdaq · Pharmaceutical Preparations · Inc. NY
What they're doing
Between 2026-08-02 and 2026-10-31, public records show 3 signals for REGENERON PHARMACEUTICALS, INC.. Most notable: 2026-09-25: Won $277.8M federal contract action from Department of Health and Human Services; 2026-09-30: Filed 8-K disclosing director or officer change; 2026-10-06: Filed 8-K disclosing material agreement. Federal contract obligations over the last 24 months total $277,052,535. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-10-31 from public records.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing director or officer change
- Federal contract awardWon $277.8M federal contract action from Department of Health and Human Services
- Large insider saleBassler Bonnie L (director) sold $1.2M of stock
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-10-14 | MURPHY ANDREW J | officer | S | 50 | 781.47 | $39,074 |
| 2026-10-14 | MURPHY ANDREW J | officer | S | 463 | 780.63 | $361,432 |
| 2026-10-14 | MURPHY ANDREW J | officer | S | 380 | 779.59 | $296,244 |
| 2026-10-14 | MURPHY ANDREW J | officer | S | 454 | 778.64 | $353,503 |
| 2026-10-14 | MURPHY ANDREW J | officer | S | 38 | 777.76 | $29,555 |
| 2026-10-14 | MURPHY ANDREW J | officer | S | 66 | 776.31 | $51,236 |
| 2026-10-14 | MURPHY ANDREW J | officer | S | 376 | 775.46 | $291,573 |
| 2026-10-14 | MURPHY ANDREW J | officer | S | 121 | 774.48 | $93,712 |
| 2026-10-14 | MURPHY ANDREW J | officer | S | 224 | 773.4 | $173,242 |
| 2026-10-14 | MURPHY ANDREW J | officer | S | 211 | 772.56 | $163,010 |
| 2026-10-14 | MURPHY ANDREW J | officer | S | 283 | 771.56 | $218,351 |
| 2026-10-14 | MURPHY ANDREW J | officer | S | 12 | 770.2 | $9,242 |
| 2026-10-14 | MURPHY ANDREW J | officer | S | 127 | 769.3 | $97,701 |
| 2026-10-14 | MURPHY ANDREW J | officer | S | 105 | 768.33 | $80,675 |
| 2026-10-14 | MURPHY ANDREW J | officer | S | 192 | 767.39 | $147,339 |
| 2026-10-14 | MURPHY ANDREW J | officer | S | 279 | 766.47 | $213,845 |
| 2026-10-14 | MURPHY ANDREW J | officer | S | 271 | 765.39 | $207,421 |
| 2026-10-14 | MURPHY ANDREW J | officer | S | 219 | 764.4 | $167,404 |
| 2026-10-14 | MURPHY ANDREW J | officer | S | 25 | 763.76 | $19,094 |
| 2026-10-14 | MURPHY ANDREW J | officer | S | 55 | 762.57 | $41,941 |
| 2026-10-14 | MURPHY ANDREW J | officer | S | 27 | 761.36 | $20,557 |
| 2026-10-14 | MURPHY ANDREW J | officer | S | 74 | 760.65 | $56,288 |
| 2026-10-14 | MURPHY ANDREW J | officer | S | 14 | 759.96 | $10,639 |
| 2026-10-14 | MURPHY ANDREW J | officer | S | 24 | 758.16 | $18,196 |
| 2026-10-14 | MURPHY ANDREW J | officer | S | 16 | 757.68 | $12,123 |
| 2026-10-14 | MURPHY ANDREW J | officer | S | 35 | 755.91 | $26,457 |
| 2026-10-14 | MURPHY ANDREW J | officer | S | 6 | 753.76 | $4,523 |
| 2026-10-13 | MURPHY ANDREW J | officer | F | 12,853 | 754.58 | $9,698,617 |
| 2026-10-13 | MURPHY ANDREW J | officer | M | 17,000 | 381.92 | $6,492,640 |
| 2026-05-01 | RYAN ARTHUR F | director | S | 2 | 710.87 | $1,422 |
| 2026-05-01 | RYAN ARTHUR F | director | S | 5 | 711.49 | $3,557 |
| 2026-05-01 | RYAN ARTHUR F | director | S | 1 | 712.09 | $712 |
| 2026-05-01 | RYAN ARTHUR F | director | S | 2 | 714.13 | $1,428 |
| 2026-05-01 | RYAN ARTHUR F | director | S | 4 | 707.4 | $2,830 |
| 2026-05-01 | RYAN ARTHUR F | director | S | 6 | 709.45 | $4,257 |
| 2026-05-01 | RYAN ARTHUR F | director | S | 7 | 706.74 | $4,947 |
| 2026-05-01 | RYAN ARTHUR F | director | S | 14 | 705.56 | $9,878 |
| 2026-05-01 | RYAN ARTHUR F | director | S | 15 | 704.28 | $10,564 |
| 2026-05-01 | RYAN ARTHUR F | director | S | 24 | 703.46 | $16,883 |
| 2026-05-01 | RYAN ARTHUR F | director | S | 5 | 701.76 | $3,509 |
| 2026-05-01 | RYAN ARTHUR F | director | S | 15 | 702.46 | $10,537 |
| 2026-04-01 | RYAN ARTHUR F | director | S | 13 | 776.62 | $10,096 |
| 2026-04-01 | RYAN ARTHUR F | director | S | 9 | 777.42 | $6,997 |
| 2026-04-01 | RYAN ARTHUR F | director | S | 4 | 778.24 | $3,113 |
| 2026-04-01 | RYAN ARTHUR F | director | S | 40 | 779.71 | $31,188 |
| 2026-04-01 | RYAN ARTHUR F | director | S | 14 | 775.58 | $10,858 |
| 2026-04-01 | RYAN ARTHUR F | director | S | 8 | 773.59 | $6,189 |
| 2026-04-01 | RYAN ARTHUR F | director | S | 3 | 772.76 | $2,318 |
| 2026-04-01 | RYAN ARTHUR F | director | S | 1 | 771.32 | $771 |
| 2026-04-01 | RYAN ARTHUR F | director | S | 8 | 774.58 | $6,197 |
Federal contracts
24-month federal obligations: $277,052,535
- 2026-09-25 $277,818,931 · Department of Health and Human Services · INMAZEB EBOLA THERAPEUTICS
- 2026-09-16 $-766,396 · Department of Health and Human Services · DE-OBLIGATE CANCELING FUNDS ON OPTION 2, EXTEND POP FOR CLINS 0002 AND 0003 TO SEPT 25, 2027, ADD FINAL INDIRECT RATES A
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
7-day average 181 views/day vs 90-day median 180.